Top Stories

  • Tel Aviv Presentation

Clinical Leadership in Start Ups

By: Joe Mullings

I just returned from Tel Aviv, Israel after attending the ICI Conference. The conference was outstanding. I had the opportunity to present on a Sunday session that was specifically designed to be a sort of “boot camp” for entrepreneurs and start-up types. The title of my presentation was “How to Recruit the Best Athlete for Emerging Technology Companies”. The range of subjects from other presenters included financing, technology development, management of IP, etc.

After […]

  • Big Ben

PCR London Valves

By: Giovanni Lauricella

The future of the heart valve industry was encapsulated in the Queen Elizabeth II Conference Centre in the “heart” of London, England at the end of September 2014. 2,018 attendees witnessed where heart valve technologies have been and where they are going.

From a recruiter’s perspective, PCR London Valves is a congress that is crucial to attend if you fall within the spectrum of the structural heart industry. The industry’s key players within the […]

  • Golfer

Golf and U.S. Clinical Trials: How OUS Startups Typically “Under-Club” U.S. Clinical Efforts

By: Joseph Mullings

So we just watched the USA get trounced by the Europeans in Ryder Cup play this past week.  For as precise and competent as the Europeans were in their golf play…the same can’t be said of the European medical device companies that come here to the States to take on the FDA.

Nearly 40% of our search firm’s work is outside the United States.  It is a mix of our U.S. clients that are […]

International News

  • international II

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients

KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ –Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its Conformite […]

  • cash5

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million.

The agreement (signed today) calls for an upfront payment of $90 million payable upon […]

  • tax

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks
* Changes follow French breast implant safety scandal
* Plans must be approved by EU governments, lawmakers

BRUSSELS, Sept 26 (Reuters) – The European Union has proposed tougher rules on assessing the safety and monitoring the use of medical devices and […]

  • surefire infusion system

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical’s Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

“Surefire Medical developed this ground-breaking technology to provide interventional radiologists […]